$SEER

Two Revised, Non-Binding Proposals Seek to Acquire All of Seer's Class A Shares

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D. Rhea-AI Summary Seer (Nasdaq: SEER) confirmed receipt of two further revised, unsolicited, non-binding acquisition proposals for all outstanding shares of its Class A common stock. On July 28, 2026, the Radoff-JEC Group offered $2.55 per share in cash plus a contingent value right.

Original reporting
Published Jul 30, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 12:53 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$SEER
Bullish
medium confidence
Mentioned
$SEER
Relevance
8/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$SEERBullishMed
01

Why it matters

Two revised cash-plus-contingent-value bids increase competitive pressure on Seer’s process, but the non-binding nature and lack of required stockholder action keep the near-term decision path unclear.

02

Market read

Fresh competing bid prices can drive momentum and volatility in SEER, but traders must weigh deal probability versus the non-binding terms.

03

What to watch

The article does not state financing, regulatory hurdles, or whether the Special Committee has signaled openness, so traders should treat the $2.55/$2.45 as negotiation anchors, not deal certainty.

Relevance 8/10Novelty 7/10Timing: after-hours/next-session positioning following July 30 confirmation of revised bids

Background

Seer has been receiving and responding to unsolicited acquisition interest, including prior proposal activity and a Special Committee review process.

Company-level read

Ticker impact

$SEERBullishMedium confidence
Context

Seer confirmed two new revised, unsolicited, non-binding all-shares acquisition proposals at $2.55 and $2.45 per Class A share.

Expected impact

Likely supports continued volatility and bid/rumor-driven upside attempts, with downside risk if the Special Committee rejects or negotiations stall.

Evidence & confidence

The article discloses fresh proposal prices and that the Special Committee will review, but explicitly states no stockholder action is required and proposals are non-binding, limiting certainty.

Market effects

Limited direct sector read-through; this is company-specific M&A optionality rather than a sector-wide catalyst.

No clear regional spillover beyond US small-cap biotech/proteomics sentiment.

Primarily US-listed takeover dynamics; minimal global relevance indicated.

Counterpoint

Because both offers are unsolicited and non-binding, the market may be overpricing the probability of a deal closing near the bid levels.

Key entities

  • Seer, Inc.

    Nasdaq-listed proteomics company that confirmed receipt of two revised unsolicited all-shares acquisition proposals.

  • Radoff-JEC Group

    Submitted a revised unsolicited non-binding proposal to acquire all Seer Class A shares for $2.55 per share plus a contingent value right.

  • Omid Farokhzad, M.D.

    Seer Chair and CEO who submitted a revised unsolicited non-binding proposal for $2.45 per share plus two contingent value rights.

  • Seer Special Committee

    Board committee that will review both proposals and other alternatives; no stockholder action is required yet.

Related articles

$SEERMed

Seer Stock Surges 40% After Investor Presentation Highlights AI, Growth Strategy

Seer, Inc. (SEER) shares rose about 39.8% to $2.27 on Monday after the company published an investor presentation ahead of its July 28 annual meeting. Seer cited an AI-driven proteomics strategy, commercialization progress, an expanding installed base, strategic collaborations, about $220M cash with no debt, and a stated $23B proteomics market opportunity by 2034, and urged shareholders to reject activist proposals.

$SEERMed

Seer Shares Rally 30% Following Investor Update Ahead of Annual Meeting (SEER)

Seer, Inc. (NASDAQ:SEER) shares rose about 30% after the company filed an investor presentation ahead of its July 28, 2026 annual meeting. Seer cited a $23B proteomics TAM by 2034, 62% CAGR growth in installed customers since 2021, 36% lower annual cash burn since 2022, ~$220M cash and no debt, and a $50M buyback authorization. A proxy contest is ongoing.

$SEERMed

Why is Seer stock surging over 30% today? By Investing.com

Investing.com reports Seer (SEER) shares rose about 33% in pre-open trading after the company filed an investor presentation with the SEC ahead of its July 28, 2026 annual meeting. The filing cited a 36% lower annual cash burn since 2022, a 62% CAGR in installed base since 2021, and a projected $23B TAM by 2034. The move follows an unsolicited CEO proposal to buy Class A shares at $2.45 plus contingent value rights and a board special committee review.